2seventy bio, Inc. Quarterly Net Income (Loss) Attributable to Parent in USD from Q3 2020 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
2seventy bio, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q3 2020 to Q2 2024.
  • 2seventy bio, Inc. Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2024 was $24.9M.
  • 2seventy bio, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending June 30, 2024 was -$156M, a 13.3% increase year-over-year.
  • 2seventy bio, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$218M, a 14.4% increase from 2022.
  • 2seventy bio, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$254M, a 13% increase from 2021.
  • 2seventy bio, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$292M, a 143% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 -$156M $24.9M +$67M Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 -$223M -$52.7M -$5.65M -12% Jan 1, 2024 Mar 31, 2024 10-Q 2024-08-08
Q4 2023 -$218M -$56.8M -$33.7M -146% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-07
Q3 2023 -$184M -$71.6M -$3.76M -5.54% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-14
Q2 2023 -$180M -$42.1M +$35.3M +45.6% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 -$215M -$47M +$38.7M +45.1% Jan 1, 2023 Mar 31, 2023 10-Q 2024-08-08
Q4 2022 -$254M -$23.1M +$37.8M +62% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-07
Q3 2022 -$292M -$67.9M -$7.88M -13.1% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 -$284M -$77.4M +$6.62M +7.88% Apr 1, 2022 Jun 30, 2022 10-Q 2023-11-14
Q1 2022 -$291M -$85.7M +$1.49M +1.7% Jan 1, 2022 Mar 31, 2022 10-Q 2023-11-14
Q4 2021 -$292M -$61M Oct 1, 2021 Dec 31, 2021 10-K 2024-03-07
Q3 2021 -$60M +$12.1M +16.8% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-07
Q2 2021 -$84M Apr 1, 2021 Jun 30, 2021 10-Q 2022-11-07
Q1 2021 -$87.2M Jan 1, 2021 Mar 31, 2021 10-Q 2022-11-07
Q3 2020 -$72.1M Jul 1, 2020 Sep 30, 2020 10-Q 2021-12-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.